Clinical Trial Update: A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial results for an investigational regimen combining FDA-approved HIV drugs in HIV-infected subjects have been posted. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection, Infection, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2009-09-24